RAD51AP1 and metastatic malignant neoplasm: Consistent with the role of RAD51AP1 in a metastatic cancer, elevated RAD51AP1 might down‐regulate microRNA hsa‐mir‐140‐3p in OC,17 leading to reduction of survival time of breast and OC patients,18 as well as promoting ICC development and progression.19